Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v9-FR Version v2-FR
Language French French
Date Updated 2020-01-20 2019-11-01
Drug Identification Number 02367394 02367394
Brand name TARO-CARBAMAZEPINE TARO-CARBAMAZEPINE
Common or Proper name TARO-CARBAMAZEPINE TARO-CARBAMAZEPINE
Company Name TARO PHARMACEUTICALS INC TARO PHARMACEUTICALS INC
Ingredients CARBAMAZEPINE CARBAMAZEPINE
Strength(s) 100MG 100MG
Dosage form(s) SUSPENSION SUSPENSION
Route of administration ORAL ORAL
Packaging size 450 ml 450 ml
ATC code N03AF N03AF
ATC description ANTIEPILEPTICS ANTIEPILEPTICS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-11-01 2019-11-01
Estimated end date 2020-01-03 2019-11-22
Actual end date 2020-01-15
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments